Last reviewed · How we verify
NCT06338670: RECONNECT
Clinical Performance of the Osia 3 Sound Processor Compared With the Osia 2 Sound Processor in Adult Osia Implant Users
NA trial testing Cochlear Osia 3 Sound Processor in Hearing Loss, Mixed Conductive-Sensorineural in 12 participants. Completed in 23 July 2025.
23 July 2025
Quick facts
| Lead sponsor | Cochlear |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 4 July 2024 |
| Primary completion | 23 July 2025 |
| Estimated completion | 23 July 2025 |
| Sites | 1 location across Australia |
Drugs / interventions tested
- Cochlear Osia 3 Sound Processor
- Cochlear™ Osia® 2 Sound Processor
Conditions studied
- Hearing Loss, Mixed Conductive-Sensorineural — all drugs for Hearing Loss, Mixed Conductive-Sensorineural →
- Hearing Loss, Conductive — all drugs for Hearing Loss, Conductive →
Sponsor
Cochlear — full company profile →
Who can join
18 and older, any sex, with Hearing Loss, Mixed Conductive-Sensorineural or Hearing Loss, Conductive. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the clinical performance of the Osia 3 Sound Processor in comparison to the Osia 2 Sound Processor in adults with mixed or conductive hearing loss or single-sided deafness implanted with an Osia implant. Participants will attend four study visits, where they will complete various hearing assessments using the Osia sound processors.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06338670
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Cochlear trials
Trials by the same sponsor.
- NCT07077070 — Investigating Electrical Categorical Loudness Scaling Using a Mobile Research App in Experienced Adult Cochlear Implant · NA · completed
- NCT07156461 — Hearing Outcomes With the Osia 3 Sound Processor Compared to the Osia 2 Sound Processor in Adult Osia Implant Recipients · NA · completed
- NCT06298396 — Investigating Stimulation Parameter and Electrode Mode Changes on Speech Perception in Experienced Adult Cochlear Implan · NA · completed
- NCT06100393 — New Algorithms to Signal Processing for Speech Enhancement in Adult Cochlear Implant Recipients. · NA · recruiting
- NCT05763342 — A Study of Objective Fitting for Focused Multipolar Stimulation · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06338670 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cochlear
- Last refreshed: 21 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06338670.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing